This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example content
Adverse event reporting can be found at the bottom of the page
Prescribing information can be found at the bottom of the page.
Join us on 18 September 2024 to hear from Dr Mili Shah, Consultant Haematologist discussing 'Fit for Intensive Treatment - How do we Decide?' followed by a live interactive Q&A.
This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and may include reference to medicines or vaccines promoted by Pfizer.
Prescribing information can be found at the bottom of the page.
Join us on 18 September 2024 to hear from Dr Mili Shah, Consultant Haematologist discussing 'Fit for Intensive Treatment - How do we Decide?' followed by a live interactive Q&A.
This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and may include reference to medicines or vaccines promoted by Pfizer.
Dr Mili Shah is a Consultant Haematologist at King’s College Hospital NHS Foundation Trust with a specialist interest in MDS, AML and stem cell transplantation. Prior to starting as a consultant, she completed the transplant and cellular therapy fellowship at KCH. She plays an active role in current clinical trials and education- especially for FRCPath examinations for trainees. She is hoping to improve the experience of older patients being treated for AML- whether they are considered candidates for allograft for otherwise. She is currently working, alongside colleagues, on setting up a clinical trial utilising expanded cord blood in ultra-high risk AML patients.
Mylotarg®▼(gemtuzumab ozogamicin)
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2024 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024